Device Trial Radar · NCT07008768
The Purpose is to Evaluate Visual Acuity for Distance, Intermediate and Near and Additionally Contrast Sensitivity at 25% and 10% of Illumination After Implantation of Trifocal IOL, Extended Range of Vision IOL, Bifocal IOL With Low Addition and Monofocal IOL
Last checked: Nov 19, 2026Latest source record: Jun 12, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
131
Actual
Start
Jan 1, 2018
Primary completion
Oct 31, 2020
Study completion Mar 30, 2022
Sponsor
- Lead sponsor
- University Eye Hospital SvjetlostAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jun 6, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Basic science
- FDA-regulated device
- No
- Who can join
- All sexes, from 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The objective of this study was to evaluate the effect of intraocular lens (IOL) selection on visual acuity and refractive outcomes, to assess the impact of IOL type on postoperative contrast sensitivity, and to investigate whether IOL choice influences the induction and dynamics of higher-order ocular aberrations following cataract surgery/refractive lens exchange surgery in hyperopic patients.
Conditions
- Cataract
- Presbyopia Correction
- Visual Acuity
Interventions
Cataract surgery and refractive lens exchange surgeryProcedure
Cataract surgery or refractive lens exchange surgery was performed with standard phacoemulsification procedure using micro coaxial surgical technique. After superior clear corneal incision, anterior capsulorexis and lens phacoemulsification, the IOL was implanted into the capsular bag using an injector in all cases. Ophthalmic Viscosurgical Device (OVD) was completely removed by irrigation and aspiration. All incisions were self-closing.
TRIFOCAL IOLDevice
1-piece aspheric hydrophobic presbyopia-correcting intraocular lens, trifocal
EROV IOLDevice
1-piece aspheric hydrophobic presbyopia-correcting intraocular lens, extended range of vision (EROV)
BIFOCAL IOLDevice
1-piece aspheric hydrophobic presbyopia-correcting intraocular lens, bifocal with low addition
MONOFOCAL IOLDevice
Control lens: 1-piece aspheric hydrophobic monofocal aspheric IOL
Primary outcomes
What the sponsor says the trial is designed to measure.
- Uncorrected and Corrected Visual Acuity changes for distance, intermediate, and near in all four groups during the follow upTime frame: 12 months
- Higher-order aberration changes in all four groups during the follow upTime frame: 12 months
- Contrast sensitivity changes at 25% and 10% illumination in all four groups during the follow upTime frame: 12 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Univestity Eye Hospital Svjetlost
Zagreb, Croatia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.